Towa Pharmaceutical Co. Ltd. Reports Earnings Results for the Third Quarter of the Year Ending March 2014; Revised Earnings Guidance for Year Ending March, 2014
February 09, 2014
Share
Towa Pharmaceutical Co. Ltd. reported earnings results for the third quarter of the year ending March 2014. For the period, the company reported net sales of JPY 45,225 million compared to JPY 41,704 million a year ago. Operating income was JPY 6,387 million compared to JPY 6,754 million a year ago. Ordinary income was JPY 7,597 million compared to JPY 7,526 million a year ago. Net income was JPY 5,139 million compared to JPY 4,998 million a year ago. On consolidated without Daichi Kasei basis, the company reported net sales of JPY 45,225 million compared to JPY 41,704 million a year ago. Operating income was JPY 6,441 million compared to JPY 6,754 million a year ago. Ordinary income was JPY 7,659 million compared to JPY 7,526 million a year ago. Net income was JPY 5,270 million compared to JPY 4,998 million a year ago.
For the period, on non- consolidated, the company reported net sales of JPY 43,961 million compared to JPY 40,504 million a year ago. Operating income was JPY 6,324 million compared to JPY 6,628 million a year ago. Ordinary income was JPY 7,545 million compared to JPY 7,396 million a year ago. Net income was JPY 5,200 million compared to JPY 4,924 million a year ago.
The company revises earnings guidance for the year ending March, 2014. For the period, the company expects net sales of JPY 61,300 million, operating income of JPY 9,000 million, ordinary income of JPY 9,700 million and net income of JPY 6,600 million.
Towa Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals. The main products are generic drugs, which are launched after the efficacy and safety of new drugs have been confirmed for a certain period of time. It is a drug with the same effect, usage and dosage. The Company is involved in the sale and outsourced manufacture of products and generic drugs. The Company is involved in the research and outsourced manufacture of active pharmaceutical ingredient and soft capsules. The Company is also involved in the planning, development, contract manufacturing of health foods, general foods, miscellaneous goods and others.
Towa Pharmaceutical Co. Ltd. Reports Earnings Results for the Third Quarter of the Year Ending March 2014; Revised Earnings Guidance for Year Ending March, 2014
TOWA PHARMACEUTICAL CO., LTD. 
